---
title: "Anlon Healthcare Ltd (AHCL) — Share Price, Financials & Analysis"
symbol: "AHCL"
company: "Anlon Healthcare Ltd"
canonical: "https://tapetide.com/stocks/AHCL"
isin: "INE0Y8W01025"
nse_symbol: "AHCL"
bse_code: "544497"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 979.05
generated_at: "2026-09-13T18:57:16.470Z"
---

# Anlon Healthcare Ltd (AHCL)

Canonical page: https://tapetide.com/stocks/AHCL

## Company

- **NSE Symbol:** AHCL
- **BSE Code:** 544497
- **ISIN:** INE0Y8W01025
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2025-09-03
- **CEO:** Mr. Punitkumar Rameshbhai Rasadia
- **Face Value:** ₹2
- **F&O Eligible:** No
- **Website:** anlon.in

## About

Incorporated in 2013, Anlon Healthcare Limited is a chemical manufacturing company engaged in the manufacturing of Pharma Intermediates and active pharmaceutical ingredients (APIs).[1]

## Latest Price

- **Price:** ₹19.57
- **Change:** +2.03 (+11.57%)
- **Open:** ₹17.73
- **Day High:** ₹20
- **Day Low:** ₹17.54
- **Previous Close:** ₹17.54
- **Volume:** 150749037
- **As Of:** 2026-09-11T10:29:57+00:00

## Key Fundamentals

Observed at 2026-09-11T04:34:06.863031Z.

- **Market Cap:** ₹979.05 Cr
- **Classification:** Microcap
- **P/E (reported):** 27.4
- **Book Value:** ₹4.33
- **Price to Book:** 4.05
- **Dividend Yield:** 0%
- **ROE:** 11.42%
- **ROCE:** 17.36%
- **Debt to Equity:** 0.19
- **Revenue (yearly):** ₹172.2 Cr
- **Net Income:** ₹29.1 Cr
- **EBITDA:** ₹47.8 Cr
- **52-Week High:** ₹18
- **52-Week Low:** ₹10.2
- **RSI (14):** 75.04

## Tapetide Score

- **Score:** 56 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Fair · Momentum: Rising
- **Percentile:** 74.1 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 63.93 | 9% |
| growth | 98.51 | 9% |
| momentum | 61.08 | 12% |
| ownership | 50 | 24% |
| quality | 41.38 | 22% |
| valuation | 51.88 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has reduced debt.

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 220 days.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -169.12% | — | — |
| ebitda margin growth | 1.96% | 3.2% | 11.78% | 158.67% |
| net income growth | -25.23% | 41.95% | 201.86% | — |
| revenue growth | 72.1% | 42.9% | 38.32% | 25.15% |
| roce | -2.86% | -31.22% | 59.04% | 9.79% |
| roe | -25.2% | -55.23% | 50.12% | -104.16% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- |
| Sales | 48.93 | 33.3 | 35.58 | 50.89 | 87.56 |
| Expenses | 31.74 | 27.06 | 23.3 | 35.6 | 71.97 |
| Operating Profit | 17.19 | 6.24 | 12.28 | 15.29 | 15.59 |
| OPM % | 35.13 | 18.74 | 34.51 | 30.05 | 17.8 |
| Other Income | 0.04 | 0.01 | 0.2 | 0.01 | 0.06 |
| Interest | 0.91 | 0.82 | 1.51 | 0.57 | 0.92 |
| Depreciation | 0.83 | 0.43 | 0.35 | 0.29 | 1.07 |
| Profit before tax | 15.49 | 5 | 10.62 | 14.44 | 13.66 |
| Tax % | -7.49 | 29.2 | 51.41 | 23.34 | 39.39 |
| Net Profit | 16.65 | 3.55 | 5.15 | 11.07 | 8.28 |
| EPS in Rs | 0.42 | 0.09 | 0.1 | 0.2 | 0.13 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2025 | Mar 2026 |
| --- | --- | --- |
| Sales | 120 | 172 |
| Expenses | 88 | 124 |
| Operating Profit | 32 | 48 |
| OPM % | 27 | 28 |
| Other Income | 0 | 0 |
| Interest | 4 | 4 |
| Depreciation | 2 | 2 |
| Profit before tax | 27 | 43 |
| Tax % | 24 | 32 |
| Net Profit | 21 | 29 |
| EPS in Rs | 0.51 | 0.54 |
| Dividend Payout % | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2025 | Mar 2026 |
| --- | --- | --- |
| Equity Capital | 40 | 53 |
| Reserves | 41 | 177 |
| Borrowings | 67 | 44 |
| Other Liabilities | 34 | 100 |
| Total Liabilities | 181 | 374 |
| Fixed Assets | 23 | 58 |
| CWIP | 0 | 0 |
| Investments | 1 | 1 |
| Other Assets | 158 | 315 |
| Total Assets | 181 | 374 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2025 | Mar 2026 |
| --- | --- | --- |
| Cash from Operating Activity | -22 | -59 |
| Cash from Investing Activity | 2 | -36 |
| Cash from Financing Activity | 19 | 118 |
| Net Cash Flow | -1 | 23 |
| Free Cash Flow | -19 | -95 |
| CFO/OP | -85 | -114 |

### Ratios

| Item | Mar 2025 | Mar 2026 |
| --- | --- | --- |
| Debtor Days | 228 | 220 |
| Inventory Days | 246 | 393 |
| Days Payable | 96 | 147 |
| Cash Conversion Cycle | 377 | 467 |
| Working Capital Days | 292 | 417 |
| ROCE % | — | 21 |

## Shareholding Pattern

### Quarterly

| Category | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- |
| Promoters | 52.68% | 52.68% | 52.68% | 52.68% | 52.68% |
| FIIs | 14.42% | 0% | 0.23% | 0.32% | 1.67% |
| DIIs | 4.35% | 2.83% | 4.49% | 4.6% | 1.22% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 14.64% | 20.73% | 23.58% | 24.38% | 26.19% |
| Others | 13.92% | 23.75% | 19.02% | 18.02% | 18.24% |
| No. of Shareholders | 9125 | 9126 | 11412 | 12484 | 34671 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 13 / 2 / 4

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 16.27 | Buy |
| EMA (10) | 16.63 | Buy |
| SMA (20) | 15.6 | Buy |
| EMA (20) | 15.96 | Buy |
| SMA (50) | 15.22 | Buy |
| EMA (50) | 15.35 | Buy |
| SMA (100) | 14.85 | Buy |
| EMA (100) | 14.82 | Buy |
| SMA (200) | 13.99 | Buy |
| EMA (200) | 14.16 | Buy |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 83.17 | Sell |
| MACD (12,26,9) | 0.68 | Buy |
| Stochastic (14,3,3) | 85.54 | Sell |
| ADX (14) | 38.56 | Buy |
| Williams %R (14) | -8.55 | Sell |
| ATR (14) | 0.82 | High Volatility |
| ROC (12) | 29.52 | Buy |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 60.69 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-07 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af2cd50d-0d97-4b38-997f-a711f9aff4f4.pdf) |
| 2026-09-05 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2414cbb-240a-4e28-b4c5-5572565d9062.pdf) |
| 2026-09-05 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bbd89c06-fc23-448f-8ac2-6ed224d2564c.pdf) |
| 2026-08-25 | [Anlon Healthcare Limited Has Informed The Exchange Regarding Corrigendum To Notice Of Annual General Meeting To Be Held On September 05 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0706808-b12b-4884-9a22-08659796b60e.pdf) |
| 2026-08-17 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=263ec273-d49c-4e8e-9b7a-85e8f7282b27.pdf) |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Monitoring Agency Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=899c184f-ebf5-4db5-b095-72d80496c847.pdf) |
| 2026-08-14 | [Notice Of 13Th Annual General Meeting Of Anlon Healthcare Limited](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0caf975e-9e81-4e93-8356-74df6c42076f.pdf) |
| 2026-08-14 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff5484fd-cd36-49e1-bcba-40fb57b36bb9.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5bc64f6-0409-43eb-95ad-80cda0da5912.pdf) |
| 2026-08-13 | [Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday August 13 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2fcfd2ba-cdb4-4727-a977-413bf839e93b.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8da202f2-9297-4e86-83fd-5403ad59405e.pdf) |
| 2026-06-09 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2fc99644-d2bd-4e6d-a5c7-6d45ac2ec55a.pdf) |
| 2026-02-24 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3c8cc31-ec84-4da8-be4d-802446c4127d.pdf) |
| 2025-11-24 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a735fe6-75a0-45a7-85ad-724bffe9cab2.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-05 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7763ec6d-baa3-4022-850f-0b3aa5faa19f.pdf) |
| 2026-06-03 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=552fac52-f267-4d36-9d20-6501f42fc2c7.pdf) |
| 2026-02-19 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e0daa815-7030-4787-b4aa-9eeb35fefda0.pdf) |
| 2025-11-19 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6cd8d26e-593d-4098-a1ba-c8f614de2aec.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-07-30 | [Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e14c129f-fa7b-4631-9825-fbcea189cde0.pdf) |
| 2026-05-29 | [Considered Approved And Taken On Record Audited Financial Results For The Quarter And Year Ended 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05537456-5b72-4589-bc74-5f0dbd3f2f51.pdf) |
| 2026-02-09 | [Anlon Helthcare Limited_Financial Results For The Quarter Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2eabc69f-8597-4b66-ab9b-32d4b7229026.pdf) |
| 2025-12-18 | [Results-Delay in Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd309e0b-70a6-4a7a-b652-8f41a8131ad6.pdf) |
| 2025-11-11 | [Financial Result For The Quarter And Half Year Ended September 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fd5c735-6df7-47e7-963f-801a348ef3f4.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6a735fe6-75a0-45a7-85ad-724bffe9cab2.pdf) |
| Nov 2017 | [Concall - Nov 2017](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2017/11/ad0dd724-cab1-470b-9fcd-e85110e90282.pdf) |
| Jun 2026 | [Concall - Jun 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/552fac52-f267-4d36-9d20-6501f42fc2c7.pdf) |
| Feb 2026 | [Concall - Feb 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a3c8cc31-ec84-4da8-be4d-802446c4127d.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Mar - Postal ballot: 1:5 stock split, increase authorised capital to Rs110 crore, 1:1 bonus; voting Mar10–Apr08,2026. | [Shareholder Meeting / Postal Ballot-Notice of Postal Ballot 9 Mar - Postal ballot: 1:5 stock split, increase authorised capital to Rs110 crore, 1:1 bonus; voting Mar10–Apr08,2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fae39c56-cd3c-4f30-b987-e99b2cb9e42b.pdf) |
| 8 May - On May 8, 2026, Anlon Healthcare acquired 63.98% of Remember India Health Links, making it a subsidiary. | [Updates On Acquisition 8 May - On May 8, 2026, Anlon Healthcare acquired 63.98% of Remember India Health Links, making it a subsidiary.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/8971704e-c999-4091-9c75-2f51c2a03ed5.pdf) |
| 6 Mar - 1:5 share split to Rs2, authorized capital to Rs110 Cr, 1:1 bonus; postal ballot; bonus by May 6, 2026. | [Board Meeting Outcome for Outcome Of Board Meeting Of Anlon Healthcare Limited Held On Friday, March 06, 2026 6 Mar - 1:5 share split to Rs2, authorized capital to Rs110 Cr, 1:1 bonus; postal ballot; bonus by May 6, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/cfc44125-9a1b-49b4-8b29-c1a9b41f78fc.pdf) |
| 27 Apr - MD Punitkumar Rasadia to give TV interview on NDTV Profit on April 27, 2026. | [Announcements Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 27 Apr - MD Punitkumar Rasadia to give TV interview on NDTV Profit on April 27, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/157a2901-4c60-4627-a07b-243c35415fb4.pdf) |
| 27 Apr - Allotted 26.57 crore 1:1 bonus shares; paid-up capital rises to Rs.106.30 crore. | [Announcement under Regulation 30 (LODR)-Allotment 27 Apr - Allotted 26.57 crore 1:1 bonus shares; paid-up capital rises to Rs.106.30 crore.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4bab5ae3-0b47-43ad-9153-7b85f7f2add4.pdf) |
| 22 Apr - New ISIN INE0Y8W01025 activated for 1:5 equity share split effective 24 April 2026. | [Intimation Of New ISIN 22 Apr - New ISIN INE0Y8W01025 activated for 1:5 equity share split effective 24 April 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/14eaed12-9e1d-4ed9-9c6c-238251c03dca.pdf) |
| 20 May 2025 - Members of the Exchange are hereby informed about the Delisting of Equity shares of Sintex Plastics Technology Limited w.e.f. May 21, 2025, pursuant to the … | [Delisting 20 May 2025 - Members of the Exchange are hereby informed about the Delisting of Equity shares of Sintex Plastics Technology Limited w.e.f. May 21, 2025, pursuant to the …](https://www.nseindia.com/get-quotes/equity?symbol=SPTL) |
| 20 Mar - Anlon Healthcare acquired 56.67% of Bizotic Life Science on March 20, 2026. | [Announcement under Regulation 30 (LODR)-Updates on Acquisition 20 Mar - Anlon Healthcare acquired 56.67% of Bizotic Life Science on March 20, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cf80ada1-a42a-4158-aaa2-64da318fbb76.pdf) |
| 1d - Shareholders approved 1:5 share subdivision and authorised capital increase to Rs.110 crore on April 8, 2026. | [Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association 1d - Shareholders approved 1:5 share subdivision and authorised capital increase to Rs.110 crore on April 8, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/172e14f9-a6be-4ab8-8112-406ef7f33d58.pdf) |
| 18 Mar - Of investor meet will be held on Saturday, March 21, 2026. Kindly take the same on your record. Thank you. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 18 Mar - Of investor meet will be held on Saturday, March 21, 2026. Kindly take the same on your record. Thank you.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0b8e26c4-5bfb-4776-aa4e-a2342b59ba63.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2025 from nse](https://archives.nseindia.com/annual_reports/AR_29220_AHCL_2024_2025_A_14092676_24012026142517.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8eb9cab8-51f0-4d73-8752-768be3bad861.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/540653/70517540653.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/540653/65461540653.pdf) |
| from bse | [Financial Year 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/540653/5406530319.pdf) |
| from bse | [Financial Year 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/540653/5406530318.pdf) |
| from bse | [Financial Year 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/540653/5406530317.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:57:16.470Z.